Intravenous Iron Infusion Injury: A Case Reviewed by a Nursing Expert Witness

Intravenous iron infusions are commonly used to treat iron deficiency, particularly in patients with renal disease, chronic illness, or those who are unable to tolerate oral iron. In most cases, the treatment is straightforward and uneventful.

However, when complications occur, the consequences can be long-lasting.

This case involved a renal patient who attended a hospital day unit for a routine infusion of Monover, an intravenous iron preparation. Instead of leaving with improved symptoms, the patient developed permanent discolouration of the arm after the iron leaked from the vein into the surrounding tissue.

An Apex intravenous iron infusion injury expert witness was instructed to assess whether the nursing care provided met an acceptable standard and whether the injury could reasonably have been avoided.

The expert identified concerns regarding cannulation technique, staff competence, site selection, monitoring, escalation, consent, and documentation. Taken together, these issues raised significant questions about whether appropriate safeguards had been in place.

The background to the case

The patient attended the day unit for a planned intravenous iron infusion as part of the management of her renal condition. Cannulation was undertaken by a nurse who was still completing cannulation training. The cannula was inserted into the antecubital fossa, the area at the front of the elbow.

Shortly after the infusion began, the patient reported pain at the cannula site. According to her account, the discomfort was significantly worse than she had experienced during previous infusions. Despite this, the infusion continued. Within approximately 20 minutes, visible discolouration had developed around the cannula site. The patient photographed the area, and the changes later proved consistent with extravasation of the intravenous iron into the surrounding tissues.

The staining became permanent.

Why cannula placement mattered

One of the key concerns identified by the nursing expert was the location of the cannula. The antecubital fossa is a high-flexion area. Movement of the elbow can affect cannula stability and increase the possibility of displacement during treatment.

For an infusion where extravasation carries the potential for permanent tissue staining, site selection becomes particularly important. A more stable area of the forearm may reduce movement around the cannula and allow the insertion site to be monitored more easily throughout treatment.

In this case, the expert considered the choice of a flexion site to have increased the risk of cannula movement and made close observation especially important. The concern was therefore not simply that extravasation occurred, but whether the decisions made before the infusion increased the likelihood of it happening.

Pain should have triggered reassessment

Pain during an intravenous infusion should never be dismissed without assessment. The patient reported significant discomfort shortly after the infusion commenced. There was also concern regarding the absence of documented blood flashback during cannulation, potentially raising questions about whether the cannula had been correctly positioned from the outset.

When pain occurs during an infusion, the cannula site should be assessed promptly for signs of extravasation or infiltration. These can include swelling, tenderness, resistance, leaking around the cannula, changes in skin colour, or changes in the flow of the infusion.

In this case, the appearance of visible discolouration provided an additional warning sign. The expert was concerned that the infusion was not stopped quickly enough once these features became apparent. With intravenous iron, early recognition is particularly important because iron deposited in the surrounding tissue can result in persistent brown or grey skin staining.

The importance of monitoring during IV therapy

The review also identified shortcomings in the documented monitoring of the cannula. There was no clear evidence that a Visual Infusion Phlebitis, or VIP, score had been recorded before or during the infusion.

VIP scoring is commonly used in clinical practice to assess peripheral intravenous cannula sites and identify signs of inflammation or other complications. Although a VIP score cannot prevent every episode of extravasation, structured monitoring provides evidence that the site has been actively assessed.

In this case, the lack of documented monitoring made it more difficult to establish when changes at the cannula site first became apparent and how staff responded. This is an important medico-legal point. Good documentation does not merely record that treatment took place. It demonstrates that appropriate observations were made, risks were considered, and changes in a patient's condition were acted upon.

The role of staff competence and supervision

The experience of the nurse carrying out the cannulation also came under scrutiny. The nurse was still undergoing cannulation training, and the hospital was reportedly unable to provide clear evidence that the relevant competencies had been completed.

Training itself is not necessarily problematic. Healthcare professionals must develop practical skills through supervised clinical experience. However, the level of supervision and the complexity of the procedure must be appropriate.

Where an intravenous treatment carries a recognised risk of permanent tissue staining following extravasation, the expert considered that particular attention should have been given to the competence of the person undertaking the cannulation and administering the infusion. The issue was therefore not simply that a trainee was involved. It was whether the trainee had been appropriately assessed, supervised, and supported for the treatment being delivered.

Consent and patient information were also questioned

Another area of concern was whether the patient had been properly informed about the risks associated with intravenous iron. The records did not demonstrate that she had received written information explaining the possibility of permanent skin staining in the event of extravasation.

According to the evidence reviewed, she had not been specifically warned about this complication. This mattered because informed consent is not limited to obtaining agreement for treatment. Patients should be given sufficient information about material risks so that they can understand what the procedure involves and make an informed decision.

Where a complication can lead to a permanent cosmetic change, that information may be particularly significant to the patient. Clear information can also help patients recognise warning signs during treatment and report symptoms such as pain, swelling, or unusual discolouration promptly.

Gaps in local guidance raised further concerns

The expert also reviewed the guidance available to staff. No clear local policy specifically addressing iron extravasation could be identified, while the hospital's own Monover monograph did not appear to adequately highlight the risk of tissue injury or long-term skin staining.

This raised broader questions about whether staff had been given sufficient guidance to recognise and respond to this particular complication. Clinical safety relies not only on individual competence but also on the systems surrounding healthcare professionals.

Policies, medicine guidance, training, competency assessments, and escalation procedures should work together to reduce foreseeable risk. Where those systems contain gaps, relatively small individual errors can combine and result in significant harm.

Could the injury have been avoided?

Following review of the available records, the Apex nursing expert concluded that there were multiple opportunities where the risk of harm could potentially have been reduced. More appropriate cannula site selection, competent insertion, clear monitoring, prompt recognition of pain and discolouration, and earlier cessation of the infusion may all have altered the course of events.

The case therefore illustrates how adverse outcomes are rarely caused by a single isolated mistake. Instead, patient harm can result from several smaller failures occurring together: an unsuitable cannula site, uncertain staff competency, inadequate monitoring, delayed escalation, and incomplete patient information.

Concluding the intravenous iron infusion injury

Intravenous iron is a routine treatment, but routine does not mean risk-free. This case demonstrates why careful cannulation, appropriate supervision, ongoing observation, and rapid response to warning signs are essential whenever intravenous iron is administered.

It also reinforces the importance of clear documentation and informed consent. If a patient reports pain during an infusion, particularly where visible changes are developing around the cannula site, staff should reassess immediately rather than assuming the infusion can safely continue.

For healthcare providers, the case highlights the importance of robust training and clear extravasation procedures. For legal teams, it demonstrates how a nursing expert witness can examine not only the technical act of administering an infusion, but the wider systems of supervision, monitoring, documentation, and escalation surrounding that care. When those safeguards fail, a treatment intended to improve a patient's health can leave a permanent and avoidable consequence.